This move is archived. Current quotes and coverage live on the stock page.
Get CSCI alerts:
COSCIENS Biopharma Inc. faced a significant drop in stock price today, closing down 8.81%.
In the latest trading session, COSCIENS Biopharma Inc. (CSCI.TO) saw its stock price plummet by 8.81%, closing at CA$11.80. This decline raises concerns among investors about the company's financial stability and future prospects.
Investor takeaway: Investors should closely monitor COSCIENS Biopharma's financial disclosures and operational updates, particularly given the recent volatility in its stock price.
Advertisement
COSCIENS Biopharma Inc.
CSCI.TO
CSCI.TO
COSCIENS Biopharma Inc.
WealthAwesomeMarket cap
$7.75M
52W high
$14.80
52W low
$3.30
1W change
-8.12%
Beta
1.89
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
126.2%
Annualized
90-Day Vol
335.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$8.66
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$7.68 | C$4.97 – C$11.88 |
| 60 trading days | C$8.16 | C$4.41 – C$15.10 |
| 90 trading days | C$8.66 | C$4.07 – C$18.40 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Stock Price Decline of 8.81%
COSCIENS Biopharma's market cap now stands at approximately CA$11.2 million, reflecting investor concerns over its recent financial performance.
Bull case
If COSCIENS Biopharma can successfully address its recent challenges and meet its operational commitments, it may regain investor confidence and see a rebound in its stock price.
Bear case
Ongoing uncertainty about financial reporting and the management cease trade order could lead to further declines in the stock price, as investor sentiment remains cautious.
Recent Performance Overview
Advertisement
Today, COSCIENS Biopharma Inc. saw its stock price close at CA$11.80, an 8.81% decrease from the previous trading session. This drop has raised eyebrows among investors, particularly given the company's recent announcements regarding potential delays in financial reporting.
Investor Concerns
The decline in stock price can be attributed to a combination of factors, including a management cease trade order and concerns over the timely filing of annual financial statements. Investors are advised to keep a close eye on upcoming disclosures, as these could significantly impact stock performance.
Looking Ahead
As COSCIENS Biopharma navigates these turbulent waters, the focus will be on its ability to stabilize operations and restore investor confidence. Any updates regarding its financial health or strategic initiatives will be crucial for its recovery.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
